Vaninder Dhillon/hopkinsmedicine.org
Feb 23, 2026, 16:49
Unpacking Genetic Markers for Thyroid Nodule Risks – Johns Hopkins Medicine
Johns Hopkins Medicine shared a post on LinkedIn։
“Is molecular testing in thyroid nodules helpful?
Dr. Vaninder Dhillon breaks down the latest debate from the AAO-HNSF 2025 meeting, exploring how genetic markers are reshaping risk assessment and treatment decisions.”
Read more.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 14, 2026, 15:14This Month’s F and S On Air Podcast Is Out Now – Fertility and Sterility
-
Apr 14, 2026, 14:51Lydia Akpan: Key Signs of Oocyte Dysmorphism
-
Apr 14, 2026, 14:42Emre Göksan Pabuçcu: Honored to Speak at the 12th National Gynecological Endoscopy Congress
-
Apr 14, 2026, 14:36Shivam Rathore: Why Temperature and Humidity Control in IVF Labs is Non-Negotiable?
-
Apr 14, 2026, 14:29Yannick Hurni: Attending SEUD 2026 Has Been a Powerful Reminder of What Conferences Truly Represent
-
Apr 14, 2026, 14:26Maria Cristina Sangiovanni: Honored to Have Spoken at the 12th SEUD Congress in Frankfurt!
-
Apr 14, 2026, 14:21Nikolaos Polyzos: What Will Reproductive Medicine Look Like in 10 Years?
-
Apr 14, 2026, 14:16Xavier Carcopino: Early and Organized HPV Vaccination Saves Lives
-
Apr 14, 2026, 12:52Ting Yuan: Using Endometrial Immune Profiling in Young IVF Patients